Home/Filings/4/0001209191-22-015893
4//SEC Filing

Dispersyn Gerrit 4

Accession 0001209191-22-015893

CIK 0001533040other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 7:12 PM ET

Size

5.1 KB

Accession

0001209191-22-015893

Insider Transaction Report

Form 4
Period: 2022-03-01
Dispersyn Gerrit
Chief Development Officer
Transactions
  • Tax Payment

    Common stock, $0.0001 par value

    2022-03-01$0.82/sh8,954$7,351212,327 total
Footnotes (2)
  • [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
  • [F2]Includes shares of common stock underlying unvested restricted stock units.

Issuer

Phio Pharmaceuticals Corp.

CIK 0001533040

Entity typeother

Related Parties

1
  • filerCIK 0001704417

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:12 PM ET
Size
5.1 KB